Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

about

Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

Item

http://www.wikidata.org/entity/Q39398874

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Real-World Single-Center Exper ...... epatitis C Genotype 1 Patients

@en

Real-World Single-Center Exper ...... patitis C Genotype 1 Patients.

@nl

type

Item

label

Real-World Single-Center Exper ...... epatitis C Genotype 1 Patients

@en

Real-World Single-Center Exper ...... patitis C Genotype 1 Patients.

@nl

prefLabel

Real-World Single-Center Exper ...... epatitis C Genotype 1 Patients

@en

Real-World Single-Center Exper ...... patitis C Genotype 1 Patients.

@nl

P1476

Real-World Single-Center Exper ...... epatitis C Genotype 1 Patients

@en

P2093

Alicia M Edwards

http://www.w3.org/2001/XMLSchema#string

Amy Zeigler

http://www.w3.org/2001/XMLSchema#string

Asma Siddique

http://www.w3.org/2001/XMLSchema#string

Blaire Burman

http://www.w3.org/2001/XMLSchema#string

Chia Wang

http://www.w3.org/2001/XMLSchema#string

Houghton Lee

http://www.w3.org/2001/XMLSchema#string

Richard A Kozarek

http://www.w3.org/2001/XMLSchema#string

Troy Zehr

http://www.w3.org/2001/XMLSchema#string

P2860

Telaprevir for previously untreated chronic hepatitis C virus infection

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Boceprevir for untreated chronic HCV genotype 1 infection

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Viral hepatitis: new data on hepatitis C infection.

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study.

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

P304

711-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL16447

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hyun Phil Shin

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28651301

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

5593334

http://www.w3.org/2001/XMLSchema#string